Area of research
Oncology · Genetics
Research interest
Research interests include CAR-T cell therapy research, Cancer Cells and Metastasis, Estrogen and related hormone effects, and Hematopoietic Stem Cell Transplantation.
Posoleucel, an Allogeneic, Off-the-Shelf Multivirus-Specific T-Cell Therapy, for the Treatment of Refractory Viral Infections in the Post-HCT Setting.
Anti-CD30 CAR-T Cell Therapy in Relapsed and Refractory Hodgkin Lymphoma
“Mini” bank of only 8 donors supplies CMV-directed T cells to diverse recipients
In Vivo Fate and Activity of Second- versus Third-Generation CD19-Specific CAR-T Cells in B Cell Non-Hodgkin’s Lymphomas
No Gains in Long-term Survival After Liver Transplantation Over the Past Three Decades
HER2-Specific Chimeric Antigen Receptor–Modified Virus-Specific T Cells for Progressive Glioblastoma
Trivalent CAR T cells overcome interpatient antigenic variability in glioblastoma
Clinical and immunological responses after CD30-specific chimeric antigen receptor–redirected lymphocytes
Transgenic Expression of IL15 Improves Antiglioma Activity of IL13Rα2-CAR T Cells but Results in Antigen Loss Variants
EMT cells increase breast cancer metastasis via paracrine GLI activation in neighbouring tumour cells
Clinical responses with T lymphocytes targeting malignancy-associated κ light chains
Characterization and Functional Analysis of scFv-based Chimeric Antigen Receptors to Redirect T Cells to IL13Rα2-positive Glioma
Ultra Low-Dose IL-2 for GVHD Prophylaxis after Allogeneic Hematopoietic Stem Cell Transplantation Mediates Expansion of Regulatory T Cells without Diminishing Antiviral and Antileukemic Activity
Long-term outcome after haploidentical stem cell transplant and infusion of T cells expressing the inducible caspase 9 safety transgene
Antitumor Effects of Chimeric Receptor Engineered Human T Cells Directed to Tumor Stroma
T Cells Redirected to EphA2 for the Immunotherapy of Glioblastoma